MKMonika Kaushik

Monika Kaushik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Monika Kaushik has a total of 84 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reprogramming Inflammatory Macrophages with Specialized Pro-Resolving Lipid Mediators: A Novel Immunotherapeutic Strategy for Asthma

    by Ruchita Tanu, Ashraf A. Qurtam, Gagan Prakash, Anis Ahmad Chaudhary, Nadeem Raza, Pushpender K. Sharma, Sudarshan Singh Lakhawat, Tejpal Yadav, Monika Kaushik, Vikram Kumar

    Asthma is defined as a chronic airway inflammatory disorder with over-activation of the immune system accompanied by the inability to resolve inflammation. SPMs are novel potent lipid mediators that play an important role in maintaining inflammation homeostasis and macrophages’ functional plasticity. This review will look into the potential function of SPM-programmed macrophage reprogramming as a novel therapeutic strategy for asthma. Unlike current anti-inflammatory treatments, which only focus on suppressing inflammation, SPMs can actively drive the inflammation resolution phase by promoting efferocytosis and wound healing while maintaining the defense against infection. In experimental asthma animal models, lipoxins, resolvins, protectins, and maresins have been demonstrated to alleviate inflammation and airway hyperresponsiveness, shift macrophages towards pro-resolving phenotypes and thus facilitate the resolution process. Levels of some SPM subclasses were found to be reduced in severe or uncontrolled asthmatics, indicating defective resolution pathways may contribute to asthma persistence. The mechanisms include down-regulation of pro-inflammatory cytokines, alteration of macrophage phenotype, improvement of immune homeostasis in the airway milieu, etc. These molecules have become highly promising therapeutic agents after the development of metabolically stable analogs, receptor-targeted agonists, and an improved delivery system. Multi-omics studies coupled with patient stratification based on biomarkers will potentially help in the future to develop personalized resolution-based therapy, in particular for those steroid-resistant and non-type 2 asthmatics. Nevertheless, the evidence provided so far is mainly preclinical; more challenges in terms of pharmacokinetics, formulation and formulation development, regulatory agency approval, and clinical validation remain and will be overcome through further studies, thus warranting investigation into SPM-mediated strategies for asthma and other chronic inflammatory diseases.


  • Top Cited Papers

    From nutrients to health outcomes: integrating diet, disease risk, and lifelong wellness

    by Monika Kaushik, Murugesan Vanangamudi, Sumit Sharma, Prathap Madeswara Guptha, Vijayaraj Surendran, Md. Abubakar, Sachchida Nand Rai

    Nutrition, encompassing vital macro- and micronutrients (including carbs, proteins, fats, vitamins such as D and C, and minerals like iron and calcium), is fundamental to supporting life, fostering healthy ageing, and averting disease. The information on the combined impact of dietary patterns, nutritional content, and lifestyle factors on metabolic health, disease risk, and healthy ageing is summarised in this publication. According to the discussion, both macronutrient and micronutrient surpluses and deficiencies upset metabolic homeostasis, which leads to obesity, insulin resistance, cardiovascular disease, and hepatic steatosis. Dietary habits are one of the three cornerstones of health and longevity, according to biogerontological theories of ageing. The free radical theory emphasises oxidative stress in cellular damage, and the disposable soma hypothesis emphasises the trade-off between reproduction and somatic upkeep. Clinical and epidemiological data indicate that cardiometabolic outcomes, including elevated insulin sensitivity, lipid profiles, and inflammatory markers, are strongly influenced by diet quality, dietary timing (such as time-restricted eating), and overall energy balance. The review also demonstrates how nutrients can control gene expression, signalling pathways, and epigenetic alterations in addition to serving as energy sources. Nutrient availability and disease susceptibility are largely determined by interactions between the gut microbiota, food, and human metabolism. Furthermore, individual reactions to diet are very variable due to genetic, metabolic, and environmental factors, which explains why customised nutrition plans are becoming more and more popular. The findings also show that dietary habits during childhood and adolescence have an impact on long-term disease prevention, and that combining lifestyle treatments (diet and exercise) can consistently reduce the risk of chronic illness. In order to optimise health and wellness over the course of a lifetime, the data generally supports switching from reductionist, single-nutrient dietary methods to integrated, systems-oriented strategies that take into account molecular, clinical, and sociocultural factors.


  • Open Access

    Mitochondrial Function in Neurons and Glia in Health and Its Alteration in Parkinson's Disease: A Review

    by Monika Kaushik, Mrugendra Potdar, Prathap Madeswaraguptha, Murugesan Vanangamudi, Md Abubakar, Manoj Kumar Mishra, Sachchida Nand Rai

    Introduction: Mitochondria play an important role in maintaining redox balance, energy, calcium, and the viability of neurons. The mitochondrial dysfunction is one of the primary sources of glial activation and dopaminergic neuron loss in Parkinson's disease (PD). The key biochemical elements of the pathogenesis of PD include impaired oxidative phosphorylation, elevated generation of reactive oxygen species (ROS), and impaired mitophagy. Methods: This review is a synthesis and stringent evaluation of recent experimental, clinical and genetic studies relating mitochondrial dysfunction and Parkinson's disease (PD). We examined information on bioenergetics, mitochondrial dynamics, calcium homeostasis, and interactions between neurons and glia. The molecular and therapeutic importance of therapies, such as mitophagy modulators, bioenergetic enhancers, and mitochondrial antioxidants, was investigated. The absence of Complex I, excess ROS, mitochondrial DNA damage, and nonfunctioning fusionfission cycles leads to neurodegeneration. The glial metabolic abnormalities worsen the oxidative stress and neuroinflammation, weakening the support of the neurons. The effects of impaired mitophagy are the accumulation of dysfunctional mitochondria, and the effects of calcium overload disrupt energy metabolism. Neuroprotective effects of such substances as spermidine, urolithin A, resveratrol, αlipoic acid, MitoQ, SkQ1, or CoQ10 have been shown using preclinical research. Sacrifices such as exercising and proper dieting enable the mitochondria to perform better and become stronger. Discussion: Mitochondrial dysfunction enhances the progression of PD through oxidative stress, bioenergetic breakdown, and inflammatory signalling. Attention to these related systems is an entire way to alter the direction of a disease. Conclusion: PD can be treated using an increase in mitochondrial quality control, redox regulation, and metabolic efficiency. Continued studies in the framework of precision medicine are required to validate the safety and effectiveness of mitochondrial-targeted medications.


  • Computational Approaches to Study ecDNA in Cancer Genomics

    by Monika Kaushik, Priya Chaudhary, Mohini Mondal, Rohini Armo, Nikunj Solanki, Sonal Solanki

    The mysterious and ubiquitous extrachromosomal circular DNA (ecDNA) is present independently of the chromosomal DNA in genomes of eukaryotes. ecDNA, found in eukaryotes, orchestrates cellular functions and causes illnesses, including cancer. Nevertheless, there is a wealth of untapped study potential in determining its complete impact on health and illness. A precise and clear overview of the landscape of techniques, from biogenesis to functional analysis, is provided in this chapter, which is necessary for unravelling the complexity of ecDNA. A thorough review of cutting-edge methods for studying ecDNAs, including high-throughput sequencing, bioinformatics, and experimental validations, is provided here. In cancer genomics, computational methods are essential for understanding ecDNA, especially when combined with improved sequencing techniques. To better understand the function of ecDNAs in cancer progression and oncogene amplification, these techniques use genomic data to detect, characterize, and recreate ecDNA structures. Additionally, we outline the direction for future studies, including new methodological avenues and perhaps revolutionary ways to ecDNA project design.

  • Open Access

    Microbiota-brain interaction: The role of gut-derived proteins in addressing various neurological disorders including Parkinson’s (PD) and Alzheimer’s diseases (AD)

    by Tahreen Taj, Monika Kaushik, Anas Islam, Joy Das, Bimlesh Kumar, Sadique Hussain, Mohhammad Ramzan, Sumel Ashique, Mohd Tariq, Sathvik Belagodu Sridhar, et al.


  • Inflammation and Brain Ageing: Anti-inflammatory Nutraceuticals

    by Monika Kaushik, Parameshwar Kondapuram, Devyani Rajput, Sagar Pamu, Mrugendra Potdar

  • Oxidative Stress and Antioxidants in the Aging Brain

    by Sagar Pamu, Mrugendra Potdar, Parameshwar Kondapuram, Devyani Rajput, Monika Kaushik


  • Nutraceuticals in Brain Health and Aging

    by Devyani Rajput, Mrugendra Potdar, Monika Kaushik, Parameshwar Kondapuram, Jamal Basha, Sagar Pamu


  • Anticancer Therapy with Proteolysis-targeting Chimeras [PROTACs] Targeting the Tumor-microenvironment: Development, Current State and Prospects

    by Murugesan Vanangamudi, Monika Kaushik, Prathap Madeswaraguptha, Vijayaraj Surendran, Pawan Kumar Gupta

    Targeted protein degradation is a rapidly expanding area that offers hope for novel approaches to combat drug resistance. The creation of heterobifunctional proteolysis-targeting chimeras [PROTACs], a new group of pharmaceutical compounds, has made TPD a useful method for completely getting rid of harmful proteins using regular small-molecule inhibitors. A big plus is that PROTACs can target multi-domain proteins that cannot be broken down. This is the case, particularly for proteins lacking a conserved interaction surface for small-molecule ligands SMIs and featuring smooth surfaces. Poor oral bioavailability and pharmacokinetic PK and ADMET absorption, distribution, metabolism, excretion, and toxicity characteristics are among the long-term issues with traditional PROTACs. Their larger size and more complex structure set them apart from other smallmolecule inhibitors, which is why they are so effective. Clinical studies have been conducted on a plethora of PROTAC compounds in the past 20 years, all with the goal of inducing the degradation of targets relevant to cancer. In this article, we closely examine the major developments and recent advancements in PROTAC technology. We seek to summarize and fully assess PROTAC-based targeted protein degradation studies on "undruggable" targets. Discussing their molecular structure, action mechanism, design concepts, development benefits, and obstacles will help to illustrate the significance of developing highly successful PROTAC-based techniques in treating many illnesses, including cancer treatment resistance.


  • Gut Microbiota and Postbiotic Metabolites: Biotic Intervention for Enhancing Vaccine Responses and Personalized Medicine for Disease Prevention

    by Naheed Mojgani, Sumel Ashique, Mehran Moradi, Masoumeh Bagheri, Ashish Garg, Monika Kaushik, Sadique Hussain, Sabina Yasmin, Mohammad Yousuf Ansari

    The creation of vaccines has revolutionized several aspects of the game in the fight against transmissible diseases, protecting countless individuals around the globe. Several vaccines against potentially fatal diseases such as diphtheria, pertussis, polio, measles, tetanus, influenza, and smallpox have significantly reduced disease risks and successfully immunized individuals against these serious health threats. The immune response generated by vaccination plays a crucial role in mitigating disease risks by stimulating the production of specific antibodies targeting the relevant pathogens. However, the efficacy of vaccines can vary among communities and people due to several factors, including heredity, age, sex, and preexisting health conditions. The multitude of microbes that call the human digestive tract the microbiota have a pivotal role in regulating immunological reactions to immunization, according to mounting data from both experimental models and research trials. Nutritional supplementation with beneficial microbes, such as probiotic bacteria, has been shown to have immune-related benefits, including enhancements of immune system responses, and has the potential to modify the variety that makes up the microbiota. The effectiveness of vaccines can be enhanced by using probiotics, which work by fostering a balanced gut microbiome. New research reveals that the immune response can be influenced by both live and dormant probiotic bacteria, as well as postbiotics, which are byproducts of the metabolism of probiotics. These substances have immunomodulatory functions and are essential in regulating how the immune system reacts to vaccines. This review aims to summarize the available research, explore the possible immune system functions that could explain these effects, and ultimately speculate about how postbiotics, aimed at the biotic microbiota, could improve the efficacy of vaccines. The review further addresses postbiotics’ challenges, regulatory aspects, and future directives for biotherapeutic products that could enhance vaccine efficacy and be tailored for personalized treatments. Graphical Abstract